Tenecteplase vs Alteplase for the Management of Acute Ischaemic Stroke in Norway
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Tenecteplase versus alteplase for the management of acute ischaemic stroke in Norway (NOR-TEST 2, part A): a phase 3, randomised, open-label, blinded endpoint, non-inferiority trial
Lancet Neurol 2022 Jun 01;21(6)511-519, CE Kvistad, H Næss, BH Helleberg, T Idicula, G Hagberg, LM Nordby, KN Jenssen, H Tobro, DM Rörholt, K Kaur, A Eltoft, K Evensen, J Haasz, G Singaravel, A Fromm, L ThomassenFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.